664-666R&D intensity is critical to the growth of hi-tech sectors like pharmaceuticals and information technology and is aimed at boosting innovation. In turn, innovation brings new products that could earn revenues to further boost R&D intensity1. Indian pharmaceutical industry earns nearly sixty percent of its revenues from exports and is a leader in global generics market with largest share of ANDA and DMF filings. Significant increase in patenting activity is also observed post India’s accession to TRIPS agreement in 1995 and subsequent introduction of Product Patent Regime in 20052. This study aims at establishing a causal relationship amongst R&D intensity, patents, regulatory filings and export intensity. Also, the impact of these va...
This study investigates the firm level determinants of profitability of Indian drug and pharmaceutic...
Although patent filing is increasing worldwide, it does not follow a uniform growth trend. China and...
This article demonstrates that radical regulatory changes can be tantamount to technological revolut...
136-145The impact of R&D expenditure, regulatory filings and patents granted on exports from Indian ...
243-252The paper examines the trends in exports, imports, R&D performance and patenting activities ...
The changing global environment brings about new opportunities and new markets for domestic firms in...
105-110This paper studies the impact of a restructured patent regime on the R&D expenditure and the...
2 | P a g e The Indian pharmaceutical industry’s exports began to exceed its imports in the late 198...
Recent researches for developing countries suggest knowledge generating activates is no silver bulle...
The Indian pharmaceutical business is the world's third-largest pharmaceutical sector in terms of vo...
321-329India, being a signatory of WTO agreements, has moved from no or partial patent protection to...
Until India fully implemented TRIPS in 2005, the Indian pharmaceutical industry had maintained a com...
Different shades of World Trade Organization (WTO) agreement on trade-related intellectual property ...
This study examines the firm-level R&D determinants of Indian high R&D intensive industries recogniz...
Abstract Technological progress through research and development (R&D) activities has been wide...
This study investigates the firm level determinants of profitability of Indian drug and pharmaceutic...
Although patent filing is increasing worldwide, it does not follow a uniform growth trend. China and...
This article demonstrates that radical regulatory changes can be tantamount to technological revolut...
136-145The impact of R&D expenditure, regulatory filings and patents granted on exports from Indian ...
243-252The paper examines the trends in exports, imports, R&D performance and patenting activities ...
The changing global environment brings about new opportunities and new markets for domestic firms in...
105-110This paper studies the impact of a restructured patent regime on the R&D expenditure and the...
2 | P a g e The Indian pharmaceutical industry’s exports began to exceed its imports in the late 198...
Recent researches for developing countries suggest knowledge generating activates is no silver bulle...
The Indian pharmaceutical business is the world's third-largest pharmaceutical sector in terms of vo...
321-329India, being a signatory of WTO agreements, has moved from no or partial patent protection to...
Until India fully implemented TRIPS in 2005, the Indian pharmaceutical industry had maintained a com...
Different shades of World Trade Organization (WTO) agreement on trade-related intellectual property ...
This study examines the firm-level R&D determinants of Indian high R&D intensive industries recogniz...
Abstract Technological progress through research and development (R&D) activities has been wide...
This study investigates the firm level determinants of profitability of Indian drug and pharmaceutic...
Although patent filing is increasing worldwide, it does not follow a uniform growth trend. China and...
This article demonstrates that radical regulatory changes can be tantamount to technological revolut...